Skip to main content
NIBEC CO., LTD. logo

NIBEC CO., LTD. — Investor Relations & Filings

Ticker · 138610 ISIN · KR7138610001 KO Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2023-03-22 Audit Report / Informat…
Country KR South Korea
Listing KO 138610

About NIBEC CO., LTD.

https://nibec.co.kr/en/

NIBEC CO., LTD. is a biotechnology company specializing in the research, development, and commercialization of healthcare solutions centered on proprietary peptide technology. The company's core activities involve the manufacturing of tissue regenerative biomaterials, such as dental bone grafts and collagen-based products, as well as biomaterial-based medical devices. In addition to its focus on regenerative medicine, NIBEC develops and markets a range of dental care and cosmetic products. The company is also actively engaged in the research and development of novel peptide-based drugs and bio-fusion technologies to address various therapeutic needs.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean regulatory authority (KRX). It provides the auditor's opinion (unqualified/appropriate), key financial data, and details regarding capital impairment and operating losses. While it contains financial data, it is a specific regulatory filing announcing the receipt and submission of the audit report, which fits the 'Audit Report / Information' (AR) category as it provides the results of the audit process. FY 2022
2023-03-22 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 19th fiscal year (2022) of NIBEC Co., Ltd. It contains comprehensive information including company overview, history, capital changes, and detailed business descriptions. This is a standard annual regulatory filing required by the Financial Supervisory Service and Korea Exchange in South Korea, which corresponds to the 10-K (Annual Report) category in the provided schema. FY 2022
2023-03-22 Korean
파생상품거래손실발생
Earnings Release Classification · 100% confidence The document is a regulatory disclosure regarding a 'Loss from Derivatives Trading' (파생상품거래손실발생) filed by the company NIBEC. It details the nature of the loss, the financial impact relative to equity, and the cause (valuation of financial liabilities under K-IFRS). As this is a specific regulatory disclosure of a financial event that does not fit into the other specialized categories like earnings releases or audit reports, it falls under the general regulatory filing category. FY 2022
2023-03-10 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'NIBEC'. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon.
2023-03-10 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal notification filed by the company (NIBEC) explaining the reason for holding its Annual General Meeting (AGM) on a 'concentrated date' (a date when many other companies also hold their AGMs). It provides the date of the meeting, the reason for the scheduling conflict, and confirms the notice date. This is a regulatory disclosure regarding meeting logistics rather than the AGM presentation materials themselves or a proxy statement. As it is a specific regulatory notification regarding meeting scheduling, it falls under the general regulatory filing category.
2023-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (Form 3.6) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting, agenda items (such as approval of financial statements, director appointments, and articles of incorporation changes), and proxy voting instructions. This falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.